Stem cell-derived islet cell therapy shows promise for individuals with type 1 diabetes June 26, 2023 -- An ongoing clinical trial for patients with type 1 diabetes (T1D) demonstrated the potential of stem cell-derived islet cell therapy, called VX-880, as a future treatment option for patients with type 1 diabetes (T1D), the American Diabetes Association (ADA) said on Friday.Read More
Resistant leukemia treated with base-edited T cells June 15, 2023 -- Three young patients with relapsed T-cell leukemia have now been treated with base-edited T cells, in an ongoing clinical trial collaboratively conducted by University College London (UCL) and Great Ormond Street Hospital for Children (GOSH).Read More
Asep gets Canadian grant for development of peptide-based drug delivery vehicle June 26, 2023 -- Asep Medical announced Friday that it has been awarded a grant by the NanoMedicines Innovation Network (NMIN) to develop a nanoparticle-formulated peptide solution as a drug delivery vehicle for treating chronic sinus infections caused by biofilms.Read More
Biotech firm AltPep closes $53M Series B financing round June 23, 2023 -- AltPep, a biotech firm developing early detection tests and disease-modifying treatments for amyloid diseases, on Friday announced the closing of a $52.9 million Series B financing round.Read More
Sound waves test protein-protein bond strength June 9, 2023 -- Temporary protein-protein bonds are essential for many bodily functions, including enzymatic reactions, antibody binding, and responses to medication.Read More
Scientists create cell atlas of developing human lung December 9, 2022 -- Researchers from the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute, the Gordone Institute at the University of Cambridge, and collaborators have created a spatiotemporal cell atlas of the developing human lung. From the mapping, they have identified 144 cell states in the early stages of life and their interactions in new detail.Read More
Senescent neuron discovery in brains opens path for Alzheimer's drug development December 2, 2022 -- Scientists at the Salk Institute for Biological Studies have found that neurons from people with Alzheimer's disease show deterioration and undergo a late-life stress process called cellular senescence, while senescent cells could be a way to slow neuroinflammation and neurodegeneration.Read More